JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. ALHC | 0.00 |
JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:
ALHC) with a Overweight and lowers the price target from $26 to $22.
